Found: 55
Select item for more details and to access through your institution.
Structural and load parameter estimation of a real‐world reinforced concrete slab bridge using measurements and Bayesian statistics.
- Published in:
- Structural Concrete, 2022, v. 23, n. 6, p. 3569, doi. 10.1002/suco.202100913
- By:
- Publication type:
- Article
Multi-Omic Approaches in Colorectal Cancer beyond Genomic Data.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 2, p. N.PAG, doi. 10.3390/jpm12020128
- By:
- Publication type:
- Article
A New Predictive Technology for Perinatal Stem Cell Isolation Suited for Cell Therapy Approaches.
- Published in:
- Micromachines, 2021, v. 12, n. 7, p. 782, doi. 10.3390/mi12070782
- By:
- Publication type:
- Article
Vulnerability to low-dose combination of irinotecan and niraparib in ATM-mutated colorectal cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-020-01811-8
- By:
- Publication type:
- Article
A Comprehensive Biomarker Analysis of Microsatellite Unstable/Mismatch Repair Deficient Colorectal Cancer Cohort Treated with Immunotherapy.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 1, p. 118, doi. 10.3390/ijms24010118
- By:
- Publication type:
- Article
Immunotherapy for Biliary Tract Cancer in the Era of Precision Medicine: Current Knowledge and Future Perspectives.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 2, p. 820, doi. 10.3390/ijms23020820
- By:
- Publication type:
- Article
On the forecastability of food insecurity.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-29700-y
- By:
- Publication type:
- Article
Case report of unusual synchronous anal and rectal squamous cell carcinoma: clinical and therapeutic lesson.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1187623
- By:
- Publication type:
- Article
Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221096878
- By:
- Publication type:
- Article
Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2019, v. 38, n. 1, p. N.PAG, doi. 10.1186/s13046-019-1035-0
- By:
- Publication type:
- Article
Influence of Irradiance, Flow Rate, Reactor Geometry, and Photopromoter Concentration in Mineralization Kinetics of Methane in Air and in Aqueous Solutions by Photocatalytic Membranes Immobilizing Titanium Dioxide.
- Published in:
- International Journal of Photoenergy, 2008, p. 1, doi. 10.1155/2008/283741
- By:
- Publication type:
- Article
Laboratory-Scale Photomineralization of n-Alkanes in Gaseous Phase by Photocatalytic Membranes Immobilizing Titanium Dioxide.
- Published in:
- International Journal of Photoenergy, 2006, p. 1, doi. 10.1155/IJP/2006/73167
- By:
- Publication type:
- Article
Modelling of Quantum Yields in Photocatalytic Membrane Reactors Immobilising Titanium Dioxide.
- Published in:
- International Journal of Photoenergy, 2006, p. 1, doi. 10.1155/IJP/2006/26870
- By:
- Publication type:
- Article
Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC.
- Published in:
- 2022
- By:
- Publication type:
- journal article
BRAF, MEK and EGFR inhibition as treatment strategies in BRAF V600E metastatic colorectal cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835921992974
- By:
- Publication type:
- Article
BRAF, MEK and EGFR inhibition as treatment strategies in BRAF V600E metastatic colorectal cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835921992974
- By:
- Publication type:
- Article
Molecular subtypes and the evolution of treatment management in metastatic colorectal cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920936089
- By:
- Publication type:
- Article
Pulmonary Arterial Hypertension Associated with Portal Hypertension and HIV Infection: Comparative Characteristics and Prognostic Predictors.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 10, p. 3425, doi. 10.3390/jcm12103425
- By:
- Publication type:
- Article
Mixed Neuroendocrine Non-Neuroendocrine Neoplasms of the Gastrointestinal Tract: A Case Series.
- Published in:
- Healthcare (2227-9032), 2022, v. 10, n. 4, p. 708, doi. 10.3390/healthcare10040708
- By:
- Publication type:
- Article
Pretreatment Plasma Circulating Tumor DNA RAS/BRAF Mutational Status in Refractory Metastatic Colorectal Cancer Patients Who Are Candidates for Anti-EGFR Rechallenge Therapy: A Pooled Analysis of the CAVE and VELO Clinical Trials.
- Published in:
- Cancers, 2023, v. 15, n. 7, p. 2117, doi. 10.3390/cancers15072117
- By:
- Publication type:
- Article
Correction: Ciardiello et al. Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer. Cancers 2021, 13 , 1941.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Skin Toxicity as Predictor of Survival in Refractory Patients with RAS Wild-Type Metastatic Colorectal Cancer Treated with Cetuximab and Avelumab (CAVE) as Rechallenge Strategy.
- Published in:
- Cancers, 2021, v. 13, n. 22, p. 5715, doi. 10.3390/cancers13225715
- By:
- Publication type:
- Article
How Immunotherapy Has Changed the Continuum of Care in Hepatocellular Carcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4719, doi. 10.3390/cancers13184719
- By:
- Publication type:
- Article
Biomarker-Guided Anti-Egfr Rechallenge Therapy in Metastatic Colorectal Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 8, p. 1941, doi. 10.3390/cancers13081941
- By:
- Publication type:
- Article
Clinical Practice Use of Liquid Biopsy to Identify RAS/BRAF Mutations in Patients with Metastatic Colorectal Cancer (mCRC): A Single Institution Experience.
- Published in:
- Cancers, 2019, v. 11, n. 10, p. 1504, doi. 10.3390/cancers11101504
- By:
- Publication type:
- Article
Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS‐mutant metastatic colorectal cancer.
- Published in:
- Molecular Oncology, 2019, v. 13, n. 9, p. 1827, doi. 10.1002/1878-0261.12547
- By:
- Publication type:
- Article
The Italian version of the LARS score: cross-cultural adaptation and validation. An Italian Society of Surgical Oncology-Colorectal Cancer Network (SICO-CCN) collaborative study.
- Published in:
- International Journal of Colorectal Disease, 2021, v. 36, n. 8, p. 1805, doi. 10.1007/s00384-021-03903-z
- By:
- Publication type:
- Article
Targeting EphA2 and DDR signaling can overcome the BRAF and MEK inhibitors acquired resistance in melanoma cell lines.
- Published in:
- Translational Medicine Communications, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41231-022-00133-5
- By:
- Publication type:
- Article
Panitumumab plus trifluridine/tipiracil as anti‐EGFR rechallenge therapy in patients with refractory RAS wild‐type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase II VELO trial.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 8, p. 1520, doi. 10.1002/ijc.34632
- By:
- Publication type:
- Article
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 3, p. 473, doi. 10.1002/ijc.34033
- By:
- Publication type:
- Article
The Evolving Role of Consensus Molecular Subtypes: a Step Beyond Inpatient Selection for Treatment of Colorectal Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A Predictive Pedestrian Crash Model Based on Artificial Intelligence Techniques.
- Published in:
- Applied Sciences (2076-3417), 2021, v. 11, n. 23, p. 11364, doi. 10.3390/app112311364
- By:
- Publication type:
- Article
Eating disorders mothers and their children: a systematic review of the literature.
- Published in:
- Archives of Women's Mental Health, 2020, v. 23, n. 4, p. 449, doi. 10.1007/s00737-020-01019-x
- By:
- Publication type:
- Article
Nonlinear modelling of data in photomineralization kinetics of organic micropollutants by photocatalytic membranes immobilizing titanium dioxide in membrane reactors.
- Published in:
- Journal of Chemometrics, 2008, v. 22, n. 7, p. 425, doi. 10.1002/cem.1133
- By:
- Publication type:
- Article
Final results of the CAVE trial in RAS wild type metastatic colorectal cancer patients treated with cetuximab plus avelumab as rechallenge therapy: Neutrophil to lymphocyte ratio predicts survival.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Retrospective Study of Regorafenib Versus TAS-102 Efficacy and Safety in Chemorefractory Metastatic Colorectal Cancer (mCRC) Patients: A Multi-institution Real Life Clinical Data.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Anti-EGFR Rechallenge in Patients With Refractory ctDNA RAS/BRAF wt Metastatic Colorectal Cancer: A Nonrandomized Controlled Trial.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 4, p. e245635, doi. 10.1001/jamanetworkopen.2024.5635
- By:
- Publication type:
- Article
Radiomic Parameters for the Evaluation of Response to Treatment in Metastatic Colorectal Cancer Patients with Liver Metastasis: Findings from the CAVE-GOIM mCRC Phase 2 Trial.
- Published in:
- Clinical Drug Investigation, 2024, v. 44, n. 7, p. 541, doi. 10.1007/s40261-024-01372-0
- By:
- Publication type:
- Article
Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi-targeted kinase inhibitors in pimasertib-resistant human lung and colorectal cancer cells.
- Published in:
- International Journal of Cancer, 2013, v. 133, n. 9, p. 2089, doi. 10.1002/ijc.28236
- By:
- Publication type:
- Article
PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer.
- Published in:
- Biomedicines, 2024, v. 12, n. 4, p. 809, doi. 10.3390/biomedicines12040809
- By:
- Publication type:
- Article
Effect of maternal eating disorders on mother‐infant quality of interaction, bonding and child temperament: A longitudinal study.
- Published in:
- European Eating Disorders Review, 2023, v. 31, n. 2, p. 335, doi. 10.1002/erv.2960
- By:
- Publication type:
- Article
Infant feeding behaviours and attitudes to feeding amongst mothers with eating disorders: A longitudinal study.
- Published in:
- European Eating Disorders Review, 2019, v. 27, n. 2, p. 137, doi. 10.1002/erv.2626
- By:
- Publication type:
- Article
Real-World Activity and Safety of Trifluridine-Tipiracil Plus Bevacizumab Therapy in Patients with Refractory Metastatic Colorectal Cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Un'introduzione al concetto di apocalisse dialogica. Frantumi, cocci, relitti e scorie degli scambi di battute nella poesia italiana del Novecento.
- Published in:
- L'Ospite Ingrato, 2023, n. 14, p. 73, doi. 10.36253/oi-15572
- By:
- Publication type:
- Article
Introduzione.
- Published in:
- L'Ospite Ingrato, 2023, n. 14, p. 7, doi. 10.36253/oi-15568
- By:
- Publication type:
- Article
«Testimoni di se stessi»: Statuti dell'io nella poesia contemporanea.
- Published in:
- L'Ospite Ingrato, 2022, v. 11, n. 1, p. 1
- By:
- Publication type:
- Article
Liquid Biopsy at Home: Delivering Precision Medicine for Patients with Cancer During the COVID-19 Pandemic.
- Published in:
- Oncologist, 2022, v. 27, n. 8, p. e633, doi. 10.1093/oncolo/oyac071
- By:
- Publication type:
- Article
Alberto Comparini, Un genere letterario in diacronia. Forme e metamorfosi del dialogo nel Novecento.
- Published in:
- Enthymema, 2019, n. 24, p. 542, doi. 10.13130/2037-2426/11559
- By:
- Publication type:
- Article
Beyond N staging in colorectal cancer: Current approaches and future perspectives.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.937114
- By:
- Publication type:
- Article
CAVE-2 (Cetuximab-AVElumab) mCRC: A Phase II Randomized Clinical Study of the Combination of Avelumab Plus Cetuximab as a Rechallenge Strategy in Pre-Treated RAS / BRAF Wild-Type mCRC Patients.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.940523
- By:
- Publication type:
- Article